Introduction
Haemophilus influenzae is most frequently isolated from respiratory tract specimens. Two -lactamases, TEM-1 and ROB-1, have been identified in H. influenzae. 1 Ampicillin resistance arising from TEM-1 in H. influenzae was first documented in 1975. 1 ROB-1 was isolated in 1981 from an ampicillin-resistant isolate of H. influenzae and is considerably less prevalent than TEM-1.
2,3 TEM-1 and ROB-1 share limited amino acid sequence homology but have similar substrate profiles and relative rates of ampicillin hydrolysis. 1 Generally, any one isolate of H. influenzae produces only one of the two -lactamases, 2, 3 although rare isolates with both TEM-1 and ROB-1 have been reported. 3 Recently published rates of -lactamase production in H. influenzae range from 24.0 to 31.3% in Canada 4,5 and 34.2 to 36.1% in the USA. 4, 6 Doern and colleagues have suggested that the prevalence of -lactamase production among North American respiratory tract isolates of H. influenzae may have levelled off following dramatic increases during the 1980s and early 1990s. 4 In Canada, rates of resistance to cefaclor (MIC у 32 mg/L) among H. influenzae have increased from Ͻ3.2% in 1991 3 to у12% in 1997-1998. 4, 5 The prevalence of -lactamase production in the same isolates has remained relatively constant (24.0-31.3%) over the same period. Given the premiss that cefaclor is a substrate for TEM-1, albeit a significantly less ideal substrate than ampicillin, 7 we attempted to determine if increasing cefaclor resistance may be the result of a change in -lactamase profile. To do this we identified -lactamase DNA sequences by PCR in 324 recent clinical isolates of H. influenzae collected from across Canada in 1997-98. 5 The last similar study in Canada was conducted using isolates collected during 1991 3 and reported that 93.0% (146/157) of -lactamase-positive H. influenzae possessed a TEM -lactamase with the remaining 11 isolates (7%) having the ROB-1 -lactamase. As a follow-up to results found in the initial study, an additional 71 -lactamase-positive H. influenzae 6 from the USA, with variable susceptibilities to cefaclor, were also tested for the presence of TEM and ROB-1 genes.
Materials and methods

Bacterial isolates
A Canadian lower respiratory tract surveillance study conducted between September 1997 and November 1998 identified 324 (24.0%) unique clinical isolates of -lactamase-positive H. influenzae. 5 6 -Lactamase production was confirmed in each isolate using nitrocefinbased disc testing (Cefinase; BBL Microbiology Systems, Cockeysville, MD, USA) according to the manufacturer's instructions.
-Lactamase identification by PCR
TEM and ROB-1 -lactamase sequences were identified in all isolates of H. influenzae by PCR amplification.
3 TEMspecific primers were chosen from the published sequence of pBR322. 8 The primers 5Ј-TGGGTGCACGAGTG-GGTTAC-3Ј and 5Ј-TTATCCGCCTCCATCCAGTC-3Ј amplified a TEM internal sequence 525 bp in length. Thermocycling conditions for the TEM primer pair were 94°C for 5 min, 30 cycles of 94°C for 2 min, 57°C for 1 min and 72°C for 2 min, followed by a final elongation step of 10 min at 72°C. Digestion of the 525 bp amplicon with DraI (Boehringer-Mannheim, Montreal, Quebec, Canada) into 97 and 428 bp fragments confirmed amplicon identity. ROB-1-specific primers and cycling conditions were identical to those previously described by Scriver and colleagues.
3 ROB-1 amplicon identity was also confirmed with DraI digestion as previously described. 3 DNA template was obtained for PCR by heating a suspension of bacteria to 94°C for 5 min. 3 Each 50 L PCR reaction contained 15 mM Mg 2+ , 1.25 mM total dNTPs, 25 pmol of each sense and antisense primers, 2.5 units of Taq DNA polymerase (Pharmacia, Baie d'Urfe, Quebec, Canada) and double-distilled sterile water in addition to DNA template. H. influenzae ATCC 49247 was used as a negative control organism for both TEM and ROB-1 PCR assays. H. influenzae clinical isolates 103 and 546 were used as TEM-positive and ROB-1-positive control organisms, respectively. 3 
Statistical analysis
Statistical analyses used the nQuery advisor program (Statistical Solutions, San Francisco, USA) and assumed an eventual one-sample 2 test (normal approximation). TEM-and ROB-1-positive isolates of H. influenzae were assumed to be equally susceptible to each antibiotic tested. P values of Ͻ0.05 were considered significant.
Results
Of the 324 Canadian isolates tested, 294 (90.7%) were PCR-positive for TEM and 30 (9.3%) PCR-positive for ROB-1. The MICs of these isolates are presented in Table   1 . TEM-and ROB-1-positive isolates in this collection were у98.0% susceptible to amoxycillin-clavulanate, cefuroxime, cefotaxime, cefixime and imipenem regardless of the -lactamase present (Table I) . 9 All isolates oflactamase-positive H. influenzae were resistant to ampicillin (Table I) . 9 Rates of cefaclor and loracarbef resistance were significantly (P Ͻ 0.001) higher in ROB-1-positive isolates than in TEM-positive isolates (Table I) . None of the 30 ROB-1-positive isolates tested was susceptible to cefaclor or loracarbef (Table I) . Cefprozil-resistant isolates were all ROB-1-positive (Table I) . Cefuroxime resistance was only demonstrated among TEM-positive, cefaclorresistant isolates (Table I) .
Of the 71 H. influenzae isolates tested from the USA, all 20 cefaclor-susceptible isolates and all 26 cefaclor-intermediate isolates were TEM-positive (Table II) . Of the 25 cefaclor-resistant isolates tested 17 (68.0%) were ROB-1-positive and 8 (32.0%) were TEM-positive (Table II) . The MICs of these isolates are presented in Table II . All 71 isolates were resistant to ampicillin and susceptible to cefotaxime, cefixime and imipenem regardless of thelactamase present (Table II) . Two -lactamase-positive amoxycillin/clavulanate-resistant (BLPACR) isolates were identified, one being TEM-positive and cefaclor-intermediate and the other TEM-positive and cefaclor-resistant (Table II) . Again, cefuroxime resistance was only demonstrated among TEM-positive, cefaclor-resistant isolates (Table II) . At least 25% (range 25-52.9%) of cefaclorresistant H. influenzae isolates were cross-resistant to cefprozil and loracarbef regardless of the -lactamase present (Table II) . As demonstrated by the Canadian isolates, cefaclor and loracarbef resistance rates were significantly (P Ͻ 0.001) higher in ROB-1-positive isolates than in TEMpositive isolates; none of the ROB-1-positive isolates tested was susceptible to cefaclor or loracarbef (Table II) .
Discussion
A 1991 Canadian H. influenzae antibiotic resistance surveillance study reported 93.0% (146/157) of isolates as TEM-positive and the remaining 7.0% (11/157) as ROB-1-positive. 3 In other previous studies the prevalence of ROB-1 -lactamase has been reported to be 8.0% and 2.8% in hospitalized and community isolates, respectively.
2,10 The present study, in which TEM was identified in 90.7% of -lactamase-positive H. influenzae isolates and ROB-1 in the remaining 9.3% of isolates indicates that the proportion of TEM-and ROB-1 -lactamases in H. influenzae has not changed significantly (P Ͻ 0.05) in Canada during the 1990s.
The aforementioned 1991 Canadian surveillance study also reported the absence of a correlation between antibiotic susceptibilities, including cefaclor, and the presence of TEM or ROB-1 -lactamases. 3 Of the 479 -lactamasepositive isolates tested, 96.8% were susceptible to cefa-clor. 3 In contrast, in the present study, which was conducted with 1997-98 -lactamase-positive H. influenzae isolates also collected from across Canada, 66.7% (26/39) of cefaclor-resistant isolates had ROB-1 and 33.3% (13/39) had TEM. For the other four ROB-1-positive isolates cefaclor MICs were also higher (16 mg/L). A similar trend was observed among the 71 isolates 6 tested from the USA with all cefaclor-susceptible and -intermediate isolates being TEM-positive and 68.0% (17/25) of the cefaclor-resistant isolates being ROB-1-positive.
A recent Canadian antibiotic surveillance study found that 12.0% of H. influenzae isolates were resistant to cefaclor. 5 Results presented in this study have demonstrated that increasing cefaclor resistance in Canada appears not to be the result of changing -lactamase profiles among clinical isolates of H. influenzae. Therefore, consideration must be given to mutation of TEM and ROB-1 -lactamases as the most probable reason underlying increases in cefaclor resistance. As previously demonstrated in Escherichia coli and Klebsiella pneumoniae, one to four amino acid substitutions in the TEM-1 enzyme or its promoter region can result in hyperproduction of -lactamase or a change in substrate specificity. 1 Similarly, the TEM-1 -lactamase in some isolates of H. influenzae may have acquired mutations that make cefaclor a more favourable substrate for this enzyme. 1 Compared with the TEM -lactamase, ROB-1 is largely unstudied and little is known of its activity against cefaclor. Mutations in the ROB-1 enzyme have not been described previously, but may help to explain the high prevalence of ROB-1 among the cefaclor-resistant isolates of H. influenzae studied here. The data may also suggest that ROB-1 may be a more potent hydrolyser of cefaclor than TEM. It is also possible that another -lactamase gene, distinct from TEM and ROB-1, may have been introduced into H. influenzae and co-exists compatibly with TEM or ROB-1 to confer resistance.
In conclusion, the -lactamase profile of H. influenzae in Canada appears not to have changed between 1991 and 1997-98, but -lactamase-positive cefaclor-resistant H. influenzae harboured ROB-1 -lactamase more commonly (P Ͻ 0.001) than TEM. The significant increases in cefaclor resistance appear to have occurred in the absence of a change in -lactamase profile, suggesting that mutation and/or changes in the expression of -lactamase genes and/or alterations in penicillin-binding proteins may be responsible. As defined by the NCCLS.
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